A second device trial is in the start-up phase in our office. AcuFocus ACI 7000, is a corneal inlay designed to correct presbyopia (“My arm’s not long enough”). It requires a 30-minute out patient procedure along with follow up visits over three years. To qualify for this study, you must be between the ages of 45-55 years old, no prior eye surgery and meet other medical criteria that will be evaluated by your doctor.

Our office will be an investigational site for the upcoming CORE study. Enrollment should begin in the second quarter. This is a device study using a new punctual plug delivery system of a glaucoma drug, allowing for a slow-release delivery of the medication without the need for use of daily drops. We are looking for subjects with glaucoma or those who are considered a glaucoma suspect and are currently using Xalatan, Travatan or Lumigan.

If you are interested in either of these clinical trials, please call Dr. Monica Robinson at (916) 649-1515.